GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SDMHF) » Definitions » Current Deferred Revenue

Sartorius Stedim Biotech (Sartorius Stedim Biotech) Current Deferred Revenue : $0 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Sartorius Stedim Biotech Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Sartorius Stedim Biotech's current deferred revenue for the quarter that ended in Dec. 2023 was $0 Mil.

Sartorius Stedim Biotech Current Deferred Revenue Historical Data

The historical data trend for Sartorius Stedim Biotech's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Current Deferred Revenue Chart

Sartorius Stedim Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sartorius Stedim Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sartorius Stedim Biotech Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech (Sartorius Stedim Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SDMHF) » Definitions » Current Deferred Revenue
Comparable Companies
XPAR:AMPLI XPAR:ALCJ XPAR:ALVMG XPAR:ALSPW XPAR:ALICR XPAR:EL ISRG BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST TSE:4543 XSWX:STMN BAX COO HOLX TSE:7733 XTER:AFX
Traded in Other Exchanges
SRTOY:USA DIM:Mexico DIMp:UK 0RG8:UK DIM:France 56S1:Germany
Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Website
https://www.sartorius.com
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.